Centralsjukhuset, Karlstad

Karlstad 65230

3 studies enrolling now · 8 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Cardiovascular Disease, Cardiovascular Diseases, Cardiovascular Risk, Cerebrovascular Disease, Chronic Kidney Disease, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Generalized Myasthenia Gravis, Heart Failure, Hypertension

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) — Recruiting now
• International Care Bundle Evaluation in Cerebral Hemorrhage Research — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early